The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Expanded biomarker analysis of an international, open-label phase 2 study of regorafenib plus pembrolizumab in patients with advanced hepatocellular carcinoma (HCC) previously treated with immune checkpoint inhibitors (ICI).
 
Anthony El-Khoueiry
Honoraria - Agenus; AstraZeneca/MedImmune; Bristol-Myers Squibb; EISAI; Elevar Therapeutics; Exelixis; Merck; Qurient; Roche/Genentech; Senti Biosciences; SERVIER; TERUMO
Consulting or Advisory Role - Agenus; AstraZeneca/MedImmune; Bristol-Myers Squibb; Eisai; Elevar Therapeutics; Exelixis; Genentech; Merck; Qurient; Roche; Senti Biosciences; SERVIER; TERUMO
Research Funding - Astex Pharmaceuticals; AstraZeneca; Auransa; Fulgent Genetics
Travel, Accommodations, Expenses - Affimed Therapeutics
 
David Balli
Employment - Bayer
 
Jean-Frédéric Blanc
Honoraria - AstraZeneca; Bayer Schering Pharma; Eisai; INCYTE; IPSEN; Roche; SERVIER
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; IPSEN; ROCHE; SERVIER; Taiho Pharmaceutical; Taiho Pharmaceutical
Travel, Accommodations, Expenses - AstraZeneca; IPSEN; Roche
 
Olivier Rosmorduc
No Relationships to Disclose
 
Thomas Decaens
No Relationships to Disclose
 
Philippe Mathurin
No Relationships to Disclose
 
Philippe Merle
Consulting or Advisory Role - AstraZeneca; Bayer; Ipsen; MSD; Roche
Research Funding - Ipsen
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; MSD; Roche
 
Farshid Dayyani
Consulting or Advisory Role - AstraZeneca; Eisai
Speakers' Bureau - Astellas Pharma; Exelixis; ipsen; SERVIER; Sirtex Medical
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech (Inst); Ipsen (Inst); Merck (Inst); Taiho Pharmaceutical (Inst)
 
Gianluca Masi
Consulting or Advisory Role - AstraZeneca; Eisai; MSD Oncology; Roche; Roche; TERUMO
Research Funding - Terumo (Inst); Terumo (Inst)
Patents, Royalties, Other Intellectual Property - Terumo (Inst)
 
Tiziana Pressiani
Consulting or Advisory Role - AstraZeneca; Bayer
Research Funding - AstraZeneca; Roche
 
Peter Galle
Honoraria - Adaptimmune; AstraZeneca/MedImmune; Bayer Schering Pharma; Bristol-Myers Squibb; Ipsen; MSD; Roche/Genentech; Sirtex Medical
Consulting or Advisory Role - Adaptimmune; Bayer Schering Pharma; Boston Scientific; Bristol-Myers Squibb; Lilly; MSD; Roche/Genentech; Sirtex Medical
Speakers' Bureau - AstraZeneca; Bayer Schering Pharma; BMS GmbH & Co. KG; Ipsen; Lilly; Roche
Research Funding - Roche/Genentech
Travel, Accommodations, Expenses - AstraZeneca; Bayer Schering Pharma; Lilly; Roche/Genentech; Sirtex Medical
 
Ken Hatogai
Employment - Merck
 
Udo Mueller
Employment - ClinStat
Consulting or Advisory Role - Bayer (Inst)
 
Stacey Kalambakas
Employment - Bayer
 
Anke Weispfenning
Employment - Bayer
 
Yuko Ishii
Employment - Bayer
 
Mohamed Bouattour
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Lilly; MSD; Roche
Speakers' Bureau - Bayer; MSD; Roche; Sirtex Medical
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Ipsen; Roche